ArticleScientific reports2025
Predicting noncoding RNA and disease associations using multigraph contrastive learning.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- PMPIHGLL: predicting metabolite-protein interactions using dual hypergraph convolutional networks and large language models.Briefings in bioinformatics · 2026Article
- AMFCL: Predicting miRNA-Disease Associations Through Adaptive Multi-source Modality Fusion and Contrastive Learning.Interdisciplinary sciences, computational life sciences · 2026Article
- Computational understanding of non-coding RNA pairwise interactions.Frontiers in artificial intelligence · 2026Article
- ESAE-SDA: ensemble sparse autoencoder framework for epigenomics-informed snoRNA-disease associations prediction.BMC bioinformatics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
MiRNAs and lncRNAs are two essential noncoding RNAs. Predicting associations between noncoding RNAs and diseases can significantly improve the accuracy of early diagnosis.With the continuous breakthroughs in artificial intelligence, researchers increasingly use deep learning methods to predict associations. Nevertheless, most existing methods face two major issues: low prediction accuracy and the limitation of only being able to predict a single type of noncoding RNA-disease association. To address these challenges, this paper proposes a method called K-Means and multigraph Contrastive Learning for predicting associations among miRNAs, lncRNAs, and diseases (K-MGCMLD). The K-MGCMLD model is divided into four main steps. The first step is the construction of a heterogeneous graph. The second step involves down sampling using the K-means clustering algorithm to balance the positive and negative samples. The third step is to use an encoder with a Graph Convolutional Network (GCN) architecture to extract embedding vectors. Multigraph contrastive learning, including both local and global graph contrastive learning, is used to help the embedding vectors better capture the latent topological features of the graph. The fourth step involves feature reconstruction using the balanced positive and negative samples and the embedding vectors fed into an XGBoost classifier for multi-association classification prediction. Experimental results have shown that AUC value for miRNA-disease association is 0.9542, lncRNA-disease association is 0.9603, and lncRNA-miRNA association is 0.9687. Additionally, this study has conducted case analyses using K-MGCMLD, which has validated the associations of all the top 30 miRNAs predicted to be associated with lung cancer and Alzheimer's diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.